Topics

Gilead’s Descovy Nabs Limited HIV Prophylaxis Indication Pending A New Study In Women

13:09 EDT 4 Oct 2019 | SCRIP

US FDA approves a PrEP indication for emtricitabine/tenofovir alafenamide that excludes cisgender women due to a lack of efficacy evidence;...

      

Related Stories

 

Original Article: Gilead’s Descovy Nabs Limited HIV Prophylaxis Indication Pending A New Study In Women

NEXT ARTICLE

More From BioPortfolio on "Gilead’s Descovy Nabs Limited HIV Prophylaxis Indication Pending A New Study In Women"

Quick Search

Relevant Topics

Reverse Transcriptase
Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...